Cynosure Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $415K | Buy |
2,237
+569
| +34% | +$106K | 0.05% | 258 |
|
|
2025
Q1 | $349K | Sell |
1,668
-107
| -6% | -$22.4K | 0.05% | 230 |
|
|
2024
Q4 | $315K | Sell |
1,775
-855
| -33% | -$152K | 0.05% | 191 |
|
|
2024
Q3 | $519K | Buy |
2,630
+394
| +18% | +$77.8K | 0.08% | 149 |
|
|
2024
Q2 | $384K | Buy |
2,236
+357
| +19% | +$61.2K | 0.06% | 235 |
|
|
2024
Q1 | $342K | Buy |
+1,879
| New | +$342K | 0.06% | 179 |
|
|
2023
Q3 | – | Sell |
-5,307
| Closed | -$715K | – | 139 |
|
|
2023
Q2 | $715K | Buy |
+5,307
| New | +$715K | 0.22% | 93 |
|